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Background: The Whiplash Disability Questionnaire (WDQ) poses a validated tool for the assessment of patients
who experience whiplash-associated disorders. A German translation and cross-cultural adaptation was recently
produced and presented high validity and internal consistency. As a follow-up, the presented study tests the
translated Whiplash Disability Questionnaire’s (WDQ-G) retest reliability and responsiveness to change.
Methods: The WDQ-G was assessed on three different measurement events: first upon entry (ME1), second four
days after entry (ME2), and third at discharge (ME3). Test-retest reliability data from ME1 and ME2 was analysed in a
group of stable patients to obtain the intraclass correlation coefficient (ICC) and the standard error of measurement
(SEM). To test the instrument’s responsiveness, WDQ-G change data were compared to concurrent instruments. The
probability of each instrument, to correctly distinguish patients of the stable phase (ME1 to ME2) from patients who
deemed to have improved between from ME1 to ME3, was analysed.
Results: In total, 53 patients (35 females, age = 45 ± 12.2) were recruited. WDQ-G scores changed from ME1 to ME2
by 5.41 ± 11.6 points in a stable group. This corresponds to a test-retest reliability of ICC = 0.91 (95% CI = 0.80–0.95)
with a SEM of 6.14 points. Minimal Detectable Change, at 95% confidence, was calculated to be 17 points change
in scores. Area under Receiver Operator Characteristics of the WDQ-G’s responsiveness revealed a probability of
84.6% (95% CI = 76.2%–93%) to correctly distinguish between improved and stable patients. Optimal sensitivity
(73.2%) and specificity (76.2%) was established at 11-point change.
Conclusions: High retest reliability and good responsiveness of the WDQ-G support clinical implementation of the
translated version. The data suggest, that change in total score greater than eleven points can be interpreted as
clinical relevant from a patient’s perspective. Minimal Important Change is suggested at 15 points where there is
still high specificity and a 90% confidence MDC.
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Hintergrund: Der Whiplash Disability Questionnaire (WDQ) stellt einen validierten Fragebogen zur Erfassung der
Alltagseinschränkungen bei Patienten nach kraniozervikalem Beschleunigungstrauma (KZBT) dar. Eine deutsche
Übersetzung und kulturelle Anpassung mit hoher Validität und interner Konsistenz wurde bereits erstellt und
getestet. In dieser Anschlussstudie soll die übersetzte Version auf Testwiederholung und Veränderungssensitivität
überprüft werden.
Methoden: Die deutsche Version des WDQ (WDQ-G) wurde an drei verschiedenen Messzeitpunkten getestet: zuerst
nach Eintritt (MZP1), vier Tage nach Eintritt (MZP2) und beim Austritt (MZP3). Für die Testwiederholung (Test-Retest)
wurde die Veränderung der Punktzahl von MZP1 bis MZP2 in einer Gruppe stabiler Patienten untersucht und der
Intraklassenkorrelationskoeffizient (ICC) sowie der Standardfehler der Messungen (SEM) berechnet. Für die
Veränderungssensitivität wurde die Veränderung der Punktzahl des WDQ-G mit dem von konkurrierenden
Fragebogen verglichen. Dabei wurde die Fähigkeit der Fragebogen untersucht, die stabilen Patienten aus der
ICC-Analyse von den Patienten zu unterscheiden, die gemäss eigenen Angaben sich nach der Behandlung besser
fühlten.
Resultate: Insgesamt wurden 53 Patienten (35 weiblich, Alter = 45 ± 12.2) rekrutiert. Die WDQ-G Punktezahl
veränderte sich von MZP1 bis MZP2 um 5.41 ± 11.6 in der stabilen Gruppe. Dies entspricht einem ICC von 0.91 (95%
CI = 0.80–0.95) mit einem SEM von 6.14 Punkten. Für eine statistisch relevante Veränderung (MDC) waren 17 Punkte
nötig (95% Konfidenz). Die Wahrscheinlichkeit des WDQ-G, die Patienten korrekt zu unterscheiden, lag bei 84.6%
(95% CI = 76.2%–93.0%). Optimale Sensitivität (73.2%) und Spezifizität (76.2%) sind bei einer Veränderung von 11
Punkten zu erreichen.
Schlussfolgerung: Hohe Reliabilität und gute Veränderungssensitivität unterstützen die Empfehlung, den WDQ-G
für die Einschätzung von KZBT Patienten zu nutzen. Die Resultate suggerieren eine Veränderung von 11 Punkten als
relevant aus Patientenperspektive. Um systematische Fehler des Fragebogens zu berücksichtigen, sollte eine
Veränderung unter 15 Punkten (90% Konfidenz) nicht als relevant interpretiert werden.
Schlüsselwörter: Kraniozervikales Beschleunigungstrauma, Assessments, Fragebogen, Reliabilität,
Veränderungssensitivität, ReproduzierbarkeitBackground
The Swiss National Accident Insurance Fund registered
roughly 11,000 new cases of whiplash-associated disor-
ders (WAD) causing costs of up to 270 million Swiss
Francs [1] every year. Despite a gradual increase of these
numbers over the last three decades, understanding of
the condition still remains poor. One of the few consen-
sus reached on the handling of WAD is that diagnostic
procedures and imaging techniques do not produce valid
outcomes needed for adequate diagnosis and planning of
treatments [2,3]. WAD, defined as consequences of
whiplash-like accidents, often cause multiple limitations
on various domains of life including function, activity, and
participation [2]. It is important for any clinician to prop-
erly monitor a patient’s development, be it improvement
or increase of symptoms. Pain alone as an outcome does
not provide sufficient specificity, or sensitivity and there-
fore lacks prognostic value [4,5]. A more global measure
is required that also accounts for interference with daily
living [2]. In the past two decades there have been two
noteworthy projects attempting to produce recommenda-
tions concerning handling cases of WAD: the Quebec
Task Force (QTF) on WAD [3] and, as part of the Boneand Joint Decade 2000–2010, the Task Force on Neck
Pain and Its Associated Disorders [2]. Both publications
contributed vastly to the understanding of the complex
nature of whiplash and the classification of subgroups in
patients allowing a more specific therapy. However, the
QTF does not provide instrument with respect to the pre-
dictive value, sensitivity, specificity, and acceptability of
diagnostic tests [2]. Accordingly, clinical decision-making
still lacked an appropriate monitoring tool sensitive to
change regarding self-perceived health status. Based on
Hoving’s qualitative research [6], Pinfold et al. proposed
the Whiplash Disability Questionnaire (WDQ) “designed
to evaluate whiplash-related disability” [7]. The WDQ is a
self-administered outcome measure to evaluate pain
intensity and limitations due to a WAD in different do-
mains: current pain level, personal care, role performance,
mobility, sleep disturbances, tiredness, social and leisure
(sporting and non-sporting) activity, emotional and cogni-
tive impairments. It is a self-administered disease-specific
questionnaire consisting of 13 items to which the patients
respond by circling their personal agreement on an 11-
point scale (zero to ten) for each item. The higher the total
score the higher the subjective perceived impairment. Its
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been approved to be a valid tool to describe and monitor
the perceived participation in everyday activity of patients
with WAD [7,8].
Considering these positive results of the English version
and after identifying the lack of an assessment with com-
parable quality criteria for German speaking regions, a
project was initiated in 2004 to produce a culturally
adapted and evaluated German translation of the WDQ.
In an article published by Schuster et al. [9] (German
translation, cross-cultural adaptation and validation of
the Whiplash Disability Questionnaire) a standardised six-
step translation process is described to produce a
German version of the Whiplash Disability Question-
naire, the WDQ-G. The translated questionnaire was
tested on 70 patients with WAD. The report suggests
good concurrent validity (r = 0.71–0.74), high internal
consistency (α = 0.89), and recommends its application
with German-speaking patients with WAD.
To allow cross-national comparison of outcomes and
international collaboration in clinical research, the trans-
lations of individual assessments must produce reprodu-
cible questionnaires and reflect the content of the
original ones [10]. The aims of the present study were to
evaluate the test-retest reliability of the German version
of the WDQ as an indicator for reproducibility in a
stable study population. Further, its ability to recognise
minimal clinical important change (MIC) after a re-




The patient study for evaluation of psychometric proper-
ties was conducted between June 2006 and September
2008 in a rehabilitation centre in the German-speaking
part of Switzerland. Four consecutive measurement
events (ME) were recorded (entry ME1, two to four days
after entry ME2, at discharge ME3, and six month after
discharge ME4). Here, only the first three MEs are
presented for analysis of test-retest reliability and
responsiveness.
Participants
For the study, a sample of German speaking men and
women after initial or repeated WAD, QTF II (neck
complaints and musculoskeletal signs [3]), with or with-
out mild traumatic brain injury – MTBI [11]) were in-
cluded if they were older than 18 years and gave written
informed consent. Patients with additional neurological
conditions (cerebrovascular insult or brain tumours),
systemic diseases (e.g. Fibromyalgia, Rheumatoid dis-
eases), psychiatric comorbidities, or reduced attention
capacities observed during the examination, were excludedfrom participation. Furthermore, patients were excluded
if they required mobility aids (e.g. walking sticks, wheel
chair, wheeled walkers).
The local ethics committee of the Canton Aargau ap-
proved the project (reference number 2005/039). All
procedures were in accordance with the Declaration of
Helsinki.Outcome measurements and measurement events
After given informed consent, patient characteristics and
accident history was recorded on the case report form
prior to ME1. The physician in charge of the entry-
examination asked patients to fill in the questionnaires
for ME1 data prior to the multidisciplinary rehabilitation
program (active and passive physiotherapy and psycho-
logical treatment). The investigator of the study handed
out the questionnaires for ME2 data two to four days
after entry (ME2). At the end of the inpatient period
(3 – 4 weeks after entry), participants were asked to fill in
the third questionnaire set (ME3). At each ME, patients
were asked to complete a set of four questionnaires: the
WDQ-G, the North American Spine Societies Question-
naire (NASS, a cervical problem-specific questionnaire),
the Medical Outcomes Study (MOS) 36-Item Short Form
Health Survey (SF-36), and the Visual Analogue Scale
(VAS) for pain. The NASS subscale for pain and disability
(NASS-PF) was used as one of the concurrent instruments
for responsiveness analysis. It consists of eleven items with
item scores ranging from one (“I can perform without
pain”) to six (“Due to my pain level I cannot perform at
all.”). A high score indicates a high degree of impairment
[10]. The official German translation has shown to be a re-
liable measure [12,13] and can be used for patients with
WAD [14,15]. The bodily pain dimension of the SF-36
physical health component (SF-36BP) was the second
comparator used for responsiveness analysis. It consists of
two items (pain magnitude and pain interference) which
score’s are coded, summed and transformed to a scale
from 0 (worst possible health state measured by the item)
to 100 (best possible health state). The SF-36 has shown
to be a reliable and valid measure of disability in different
languages for different pathologies, including WAD
[16-23]. The non-validated health transition item (HTI) of
the SF-36 was also included in the analysis to record the
change in global health perception from a patient’s per-
spective. At ME1 and ME2, the item asked: “Compared to
one ear ago, how would you rate your health in general
now?”. At ME3, after treatment, the item addressed the
change occurred since the beginning of the treatment:
“Compared to before your rehabilitation therapy, how
would you rate your health in general now?”. Five possible
answers allowed the patients to report whether they felt
their condition has strongly improved (=1), moderately
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some degree (=4), or even strongly deteriorated (=5).
On the VAS, the third comparator, patients reported
actual subjective pain intensity indicated on a horizontal
10 cm straight line anchored by two extremes of pain:
“no pain” (0 cm) and “pain as bad as it could be”
(10 cm) [23,24].
Anonymised and completed SF-36 and NASS ques-
tionnaires were scanned to upload by secure data
transfer to an independent company (RehabNET AG,
Zürich, Switzerland) for data assembly and subsequently
returned for in-house analysis. Questionnaires for demo-
graphic and descriptive statistics as well as VAS and
WDQ data were recorded manually within the clinic using
Microsoft Excel 2003.
Data analysis
Patients were dichotomised into two groups based on
their responses on the HTI. The improved group was as-
sembled from patients who responded on the HTI with
moderately or strongly improved after treatment (ME3).
The stable group, on the other hand, was assembled
from patients who presented no change in HTI score
from ME1 to ME2. Returned questionnaires were classi-
fied as incomplete if more than 2 items were missing on
the WDQ-G or any item was missing on the reference
questionnaires (VAS, SF-36BP bodily pain, and NASS-
PF pain & function). Only complete questionnaire sets
were included for analysis. Change in scores from one
ME to another was calculated and statistically compared
with the paired Student t-test. All statistical analyses
were computed on the IBM Statistical Package for Social
Sciences version 20, 2011 (IBM Corp.©) with p ≤ 0.05.
Reliability
The stable group (no change from ME1 to ME2) provided
test-retest data to calculate the Intraclass Correlation
Coefficient (ICC) as an indicator for reproducibility. The
ICCA,1 two-way random model was applied, where A
stands for absolute agreement [26]. Single measure values
of 0.65 or above were regarded as statistically acceptable
[21]. Confidence intervals (CI) were also calculated to pro-
vide upper and lower limits of the 95% certainty and the





, where SDstable represents the
baseline score of the stable group [27].
Responsiveness
As there exists considerable confusion regarding the no-
menclature for reporting and quantifying responsiveness
[27], it seems appropriate to introduce the herein ap-
plied terminology for this report. Recommendations of
Crosby et al. [28] were used as guidance with additionalconsideration of the combined approach recommended
by de Vet et al. [29] without claiming superiority over
other available terminology [27,30].
In their review on change in health-related quality of
life, Crosby et al. recommend two major approaches of re-
sponsiveness: Criterion-referenced change (or anchor-
based methods) and precision-referenced change (or
distribution-based methods). Criterion-referenced change
includes cross-sectional and longitudinal approaches,
comparing the instrument under investigation with
concurrent instruments. Precision-referenced change de-
scribes estimates based on statistical significance of the in-
strument under investigation. Estimates based on the
combined approach are termed as MIC, i.e. a criterion-
referenced change greater than precision-referenced
change could be presumed meaningful [28].
Precision-referenced change was analysed by calculat-
ing the Minimal Detectable Change (MDC) as
1:96 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ2 SEMp , which is related to the retest ICC
assessed in the stable group between ME1 and ME2
[29]. As an indicator for magnitude of change the
Standardized Response Mean (SRM) of the non-
dichotomised group was calculated as the ratio of
observed change to ME3 and its SD. The SRM has the
advantage over other effect size coefficients that it is in-
dependent of group size and proves especially valuable
when compared to concurrent measures [27]. Between-
difference variability of the individual SRM was
compared using Student’s t-distribution for qualitative
comparison of the instruments’ precision [27,31].
A small SRM would reflect high variability of the
change scores. SRM higher than 0.5 was presumed to be
adequate, SRM higher than 0.8 represents large respon-
siveness [32].
For the criterion-referenced change, the WDQ change
scores were compared to the ones of the VAS, SF-36BP,
and NASS-PF. First, Pearson’s correlation coefficients
between change scores from ME1 to ME3 of the WDQ-
G and VAS, SF-36BP, and NASS-PF were calculated [27]
from the non-dichotomised group to evaluate whether
the instruments respond in a similar way. To compare
the instruments’ ability to distinguish between improved
and stable patients, the Receiver Operating Characteris-
tics (ROC) curve was plotted. Cut-off points for all in-
struments were determined as the point on the curve
nearest to the upper left-hand corner where optimal
sensitivity and specificity is expected (where sensitivity +
(1-specificity) is minimal) [27]. A cut-off point greater
than or equal to MDC was considered to be meaningful
(=MIC) [28]. Comparison of the area under the ROC
curve (AUC) was used to assess the WDQ-G’s respon-
siveness as compared to the traditional instruments, i.e.
their probabilities to correctly distinguish between the
two phases (stable from ME1 to ME2 and improved
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referenced to the HTI.
Results
Patient study
The screening period from 2006 to 2008 revealed 159
patients diagnosed with WAD. After selection for study
criteria, the study cohort consisted of 70 patients who
agreed to participate. No dropouts were recorded, but
17 patients failed to return complete data sets leaving a
dataset of 53 patients for analysis (35 females, mean age
45 ± 12.2) referred to as non-dichotomised group. For
the recruited patients, the time since accident ranged
from 22 days to 18 years, mean time was 99 weeks for
the non-dichotomised group. Mean amount of days be-
tween ME1 and ME2 was 3.42 (±2.1) days and 21.64
(±8.3) days from ME2 to ME3. At time of admission, pa-
tients’ average employability level was 37.65% (±37.4)
with 7 patients still employed 100% (42 h/week) and 24
patients reporting not being able to work at all (0% em-
ployability). On the self-reported questionnaire, 10 pa-
tients (18%) indicated to have had MTBI from the
accident and 7 patients reported still being involved in
litigation.
After comparing MEs for dichotomisation, one im-
proved group of N = 41 (from ME1 to ME3, 27 females)
and one stable group of N = 42 (from ME1 to ME2, 31
females) patients were assembled for analysis.
Test retest reliability
Table 1 summarises the results of ME1 to ME3 showing
pre-treatment, retest, and post-treatment scores and
score changes on all questionnaires. From ME1 to ME2
the mean change score for all participants was 6.06
points (±11.3, 95% CI = 2.95 to 9.16, p < 0.001) and 5.41
(±11.6, 95% CI = 1.793 to 9.11, p < 0.001) for stable
patients. This corresponds to an ICC of 0.91 (95% CI =
0.80 to 0.95, p < 0.001) for the stable group and 0.92
(95% CI = 0.82 to 0.96, p < 0.001) for the non-
dichotomised group. For the non-dichotomised group,
maximum and minimum change from ME1 to ME2 was
47 and −16, from ME1 to ME3 it was 70 and 4, respect-
ively. The WDQ-G SEM value for the non-dichotomised
group was 6.82 and 6.16 for the stable group. Two out-
liers were identified with changes greater than 1.5 × the
inter quartile range from ME1 to ME2 with 27 and 47
points change in scores.
Responsiveness
Pearson’s r for mean WDQ-G change of the non-
dichotomised group from ME1 to ME3 with the mean
change of the SF-36BP was 0.50 (p < 0.001), 0.69 (p < 0.001)
for the NASS-PF, and 0.74 (p < 0.001) for the VAS. Change
in score from ME1 to ME3 was significant for allmeasurement events with the highest t-value for the
WDQ-G (t = 8.66) followed by the SF-36BP (t = 7.25), the
VAS (t = 6.64) and the NASS-PF (t = 4.30). Comparison of
the SRM suggests that the WDQ-G was the most respon-
sive measure with a significantly greater SRM than the
NASS-PF (95% CI = 0.22–0.65, p < 0.01) and the VAS
(95% CI = 0.08–0.48, p < 0.01) but only insignificantly
greater than the SF-36BP (95% CI = 0.12–0.42, p = 0.27).
Responsiveness results for the investigated outcomes are
summarized in Table 2.
ROC curves for the assessed instruments are pre-
sented in Figure 1. The figure shows that all instruments
have similar high probabilities to correctly assess pa-
tients as improved with AUC values higher than 0.7,
whereas the NASS-PF presented the lowest AUC. The de-
termined cut-off value for the WDQ-G has a sensitivity of
0.73 and specificity of 0.76. Thus, 26.8% of the criterion-
referenced improved patients have false-negative changes
(observed change is lower), and 23.8% have false-positive
changes (observed change is higher). By raising the cut-off
to MDC (i.e. raised to MIC), the probability of false
positives is reduced (11.9%) and the probability of false
negatives is increased (38%) [33].
Discussion
Analysis of the instrument’s systematic error revealed
strong correlations between test and retest suggesting
good reproducibility. Although the ICC calculated for
the WDQ-G (ICC = 0.91) is slightly lower than the
short-term ICC reported for the Australian version by
Willis et al. [11] (ICC = 0.96), it is still acceptable for
clinical measures [30].
Sample size was comparable to previous WDQ studies
[6-8] and provides a representative German-speaking
population with WAD. However, the considerably re-
duced sample size after exclusion of incomplete ques-
tionnaires may suggest reduced power of the reported
outcomes. Indeed, to allow 95% certainty for the ICC to
be greater than 0.86, a sample size of 73 patients would
have been required. Still, with 42 patients included there
is a 95% certainty for the ICC to be greater than 0.80,
which could still be deemed sufficient [30]. This sample
size is also justified in the light of Nunnally and
Bernstein’s observations, that ICCs greater than 0.80 are
less susceptible to measurement errors [34].
The inclusion criteria did not exclude patients with
self-reported MTBI, although there is no clear definition
as to whether this can be classified as QTF II and atten-
tional deficits could be expected. However, all participat-
ing patients underwent medical examination as part of
the admission process to the clinic and were deemed
cognitively able to fill in all questionnaires [11].
The criterion-referenced ROC curve revealed that, in
terms of sensitivity and specificity, the optimal cut-off
Table 1 Summary of outcome scores from ME1 to ME3











All 72.23 (22.3) 66.17 (24.2) 50.13 (29.1) 6.06 (11.3)* 22.09 (18.6)*
Improved$ 69.62 (19.9) 63.31 (22.2) 43.40 (25.3) 6.32 (12.4)* 26.22 (18.2)*
Stable£ 76.68 (20.1) 71.27 (22.6) 56.01 (28.9) 5.41 (11.6)* 20.67 (19.1)*
SF-36BP
All 24.96 (13.6) 26.68 (16.0) 45.30 (21.9) −1.72 (10.3) −20.34 (20.4)*
Improved$ 25.95 (11.9) 27.24 (13.4) 51.32 (18.4) −1.29 (10.8) −25.37 (19.5)*
Stable£ 22.50 (11.5) 23.00 (13.1) 42.02 (21.9) −.050 (10.8) −19.52 (20.7)*
NASS-PF
All 3.44 (0.8) 3.39 (0.8) 2.98 (1.0) 0.05 (0.4) 0.46 (0.6)*
Improved$ 3.36 (0.8) 3.31 (0.8) 2.79 (0.9) 0.04 (0.4) 0.58 (0.6)*
Stable£ 3.56 (0.8) 3.54 (0.8) 3.12 (1.0) 0.02 (0.4) 0.43 (0.6)*
VAS
All 5.79 (1.9) 5.65 (2.4) 3.54 (2.7) 0.14 (1.6) 2.25 (2.5)*
Improved$ 5.85 (1.7) 5.55 (2.3) 2.82 (2.0) 0.29 (1.7) 3.03 (2.2)*
Stable£ 6.04 (1.8) 5.95 (2.3) 4.01 (2.7) 0.09 (1.7) 2.03 (2.6)*
*stat. significant on the level of 0.01; ME Measurement Event; SD Standard Deviation; WDQ-G Whiplash Disability Questionnaire; SF-36BP 36 Item Short Form
Health Survey Bodily Pain Subscale; NASS-PF North American Spine Society Questionnaire Pain and Function Subscale $HTI < 3 from ME1 to ME3; £HTI > 3 from
ME1 to ME2.
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scores. This is less than the precision-referenced MDC,
which also accounts for systematic error. Consequently,
the cut-off should be raised to MDC to reduce effects of
the instruments measurement errors. Here we face the
problem that if we want to consider variability for esti-
mation of change and define MIC equal to MDC, the in-
strument’s ability to identify true improvement, as
defined by subjective judgment of the patient, is re-
duced. The original version of the WDQ was assessed
for responsiveness using the MDC for 90% CI withTable 2 Responsiveness statistics
Outcome WDQ-G SF-36
Precision-referenced (non-dichotomised from ME1 to ME3)
SRM 1.19 1.00
Precision-referenced (stable ME1 to ME2)
ICC (95% CI lower-upper) 0.91 (0.80–0.95) 0.76
SEM 6.14 5.58
MDC 17 16
Criterion-referenced (improved from ME1 to ME3 vs. stable from ME1 to ME2)
ROC cut-off (MIC) 11 (17)§ 16 (1
ROC AUC 0.85 (0.76–0.93) 0.880
*significant difference compared to WDQ-G SRM on the level of 0.01; ME Measurem
SF-36BP 36 Item Short Form Health Survey Bodily Pain Subscale; NASS-PF North Am
Standardised Response Mean; ICC Intraclass Correlation Coefficient; SEM Standard E
Operating Characteristics; § MIC Minimal Important Change (equals numbers in brac1.64×SEM, thus suggesting a change of 15 points to be
relevant [8]. Using the same constant for the German
version yields similar results: 14.3 points. A MIC of 15
point in the present study corresponds to sensitivity of
64% and 86% specificity.
All instruments had large t-test values suggesting high
responsiveness to the treatment for all groups from ME1
to ME3. Only the WDQ-G significantly changed in scor-
ing within the stable groups from ME1 to ME2. This
could be related to systematic score change, i.e. the high
variability in change even in stable patients. As similarBP NASS-PF VAS
0.75* 0.91*
(0.61–0.85) 0.94 (0.89–0.97) 0.79 (0.61–0.89)
0.19 0.82
0.53 2.26
6)§ 0.15 (0.6)§ 1.850 (2.3)§
(0.81–0.95) 0.78 (0.69–0.88) 0.87 (0.79–0.94)
ent Event; SD Standard Deviation; WDQ-G Whiplash Disability Questionnaire;
erican Spine Society Questionnaire Pain and Function Subscale; SRM
rror of Measurement; MDC Minimal Detectable Change; ROC Receiver
kets); AUC Area under Curve of ROC.
Figure 1 Receiver Operating Characteristics curves comparison of change scores. True positive value is “Improved”; True negative value
is “Stable”.
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might pose a potential weakness of the questionnaire to
correctly identify improved patients with high sensitivity.
Although the results presented herein suggest good
responsiveness of the WDQ-G, they are still not conclu-
sive. Some of the aspects not addressed include baseline
impairments, regression to the mean and direction of
change. It should be investigated whether patients with
more severe impairment require a greater change in
score to be considered clinically meaningful improved
than those with less severe pain. On the other hand, pa-
tients with greater impairments at baseline also have
more opportunity to improve. Speer et al. suggest that
baseline scores should therefore be adjusted for regres-
sion to the mean, e.g. by using the Edwards-Nunnally
method [35]. It should also be analysed whether deteri-
oration has different cut-off values than improvement
[28]. Further, the use of self-reported global health state
items as external criteria has been criticized extensively.
Quite rightly so, as any anchor-based approach is only
as good as the selected anchor [36]. One of its major
flaws is the lack of accepted psychometric properties.
Individual response might depend on current mood or a
recent event that may have caused problems not related
to WAD. This kind of bias cannot be excluded in a
single item. In an attempt to improve this situation, we
reflected on combining the external health transition
item of the SF-36 with one of the validated and reliable
instruments assessed alongside the WDQ-G. But apply-
ing, for instance, VAS change as external criteria wouldonly address pain, whereas an improvement (or deterior-
ation) in pain does not automatically mean reduced
impairment due to WAD. From an individual perspec-
tive, the health transition item provides a good overall
indication of the patient’s perspective on his or her
health status [28] and has been applied in similar studies
investigating responsiveness of health related quality of
life measures [37,38].
Because criterion-referenced responsiveness is inde-
pendent of time and intervention [27], it is possible to
compare the group used for testing the instrument’s
measurement precision (i.e. stable group) with a group
containing some of the patients at a later point in time
(i.e. after treatment as an improved group). Still, this
method could be criticised as it rather compares the
ability to distinguish between two phases (ME1 to ME2
versus ME1 to ME3) than between two groups after a
specific intervention and pre-specified time frame. As
the study’s aim was not to investigate the efficacy of a
particular treatment, this method seemed appropriate to
test the WDQ-G’s discriminatory performance.
A further limitation of the study design is the non-
standardised intervention. Although rehabilitation pro-
grams are often similar across the clinics in a language
specific region, they are seldom exactly the same. Thus,
the studies findings are not necessarily applicable to all
types of interventions. Included patients underwent a
multidisciplinary therapy program consisting of active
physiotherapy and exercises, passive treatments such as
massage or thermal treatments, and psychological therapy.
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ment under investigation to an external anchor reflects “a
property of measure and has a meaning in a wider range
of settings” than precision-referenced outcomes. This also
justifies the application of more than just one statistics for
responsiveness. Where the t-test is said to be a minimal
indicator for responsiveness, this study also addressed the
magnitude of change using the SRM. The SRM is advanta-
geous over other effect size methods for its ability to re-
flect measurement precision (95% CI) and thereby can be
compared statistically to other instruments. The WDQ
was specifically designed to reflect different aspects of
health status for patients with WAD, this is reflected in
relatively low Pearson’s r with change in the other instru-
ments from ME1 to ME3. Relations with external criteria
are of some interest, but they do not not provide informa-
tion on whether it actually assesses the construct in a
more specific way. Once a German version of a closely re-
lated instrument is available that has been evaluated for
psychometric properties, e.g. the Neck Disability Index, a
comparison of both instruments’ responsiveness would be
of interest.
Although the WDQ-G is not necessarily more precise
than concurrent instruments, it is easier to apply and
quicker to fill in than many of the available question-
naire’s, while at the same time being informative on all
dimensions.
Conclusion
WADs comprise a row of different symptoms that are
difficult to track reliably for professional treatment. So
far, there was no WAD-specific self-administered ques-
tionnaire covering all aspects of impairment (pain
levels, personal care, role performance, mobility, sleep
disturbances, tiredness, social and leisure (sporting and
non-sporting) activity, emotional and cognitive impair-
ments). With the English version of the WDQ a long
overdue assessment for practitioners and researchers to
monitor patients with WAD has been developed and reli-
ability and responsiveness of its translation are presented
here. The study showed that the WDQ-G is a reliable
questionnaire with comparable responsiveness as trad-
itional health related outcomes for whiplash. The decision
as to how much change is relevant might have to be based
on the individual case. The study provides necessary re-
sults for the clinician to decide, with which certainty a
specific cut-off point on the WDQ-G can be deemed
improved. A change of 11 points represents MIC from a
patient’s perspective with highest sensitivity and specifi-
city. Using the MDC with 17 points change as cut-off has
lower sensitivity but is more accurate from a statistical
point of view. Change in 15 points could be used as mid-
dle course, with 90% confidence for true change and high
specificity (86%) but reduced sensitivity (64%).The German version of the WDQ can be obtained free
of charge from the second author: Dr. Corina Schuster:
c.schuster@reha-rhf.ch.
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